ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

This study has been completed.

Sponsored by: Alcon Research
Information provided by: Alcon Research
ClinicalTrials.gov Identifier: NCT00047593
  Purpose

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.


Condition Intervention Phase
Open-Angle Glaucoma
Ocular Hypertension
Drug: IOP Lowering Medications
Phase III

Genetics Home Reference related topics:   early-onset glaucoma   

MedlinePlus related topics:   Glaucoma    High Blood Pressure   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Phase 3 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Japanese Subjects C-01-98.

Further study details as provided by Alcon Research:

Study Start Date:   January 2000
Study Completion Date:   July 2004
Primary Completion Date:   July 2004 (Final data collection date for primary outcome measure)

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Adults of Japanese Ethnicity

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00047593

Locations
United States, California
      San Francisco, California, United States
      Los Angeles, California, United States
United States, Hawaii
      Honolulu, Hawaii, United States

Sponsors and Collaborators
Alcon Research
  More Information


Study ID Numbers:   C-01-98, C-01-98
First Received:   October 8, 2002
Last Updated:   August 4, 2008
ClinicalTrials.gov Identifier:   NCT00047593
Health Authority:   United States: Food and Drug Administration

Keywords provided by Alcon Research:
open-angle  
glaucoma  
ocular  
hypertension  
POAG
Iris
Pigmentation
Japanese

Study placed in the following topic categories:
Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 20, 2008




Links to all studies - primarily for crawlers